Chiarparin, Elisabetta
AstraZeneca (United Kingdom)
4 papers on CoChatORCID 0000-0002-2998-1346
Most cited papers
- Verified
EED-Targeted PROTACs Degrade EED, EZH2, and SUZ12 in the PRC2 Complex
Hsu, J. H.-R., Rasmusson, T., Robinson, J., Pachl, F., Read, J., Kawatkar, S., O’ Donovan, D. H., Bagal, S., Code, E., Rawlins, P., et al. (2020) · Cell Chemical Biology
Protein Degradation and InhibitorsEpigenetics and DNA Methylation
Cited by 202
- Verified
Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6
McCoull, W., Cheung, T., Anderson, E., Barton, P., Burgess, J., Byth, K., Cao, Q., Castaldi, M. P., Chen, H., Chiarparin, E., et al. (2018) · ACS Chemical Biology
Protein Degradation and InhibitorsLymphoma Diagnosis and Treatment
Cited by 139
- Verified
Discovery of a Potent Nonpeptidomimetic, Small-Molecule Antagonist of Cellular Inhibitor of Apoptosis Protein 1 (cIAP1) and X-Linked Inhibitor of Apoptosis Protein (XIAP)
Tamanini, E., Buck, I. M., Chessari, G., Chiarparin, E., Day, J. E. H., Frederickson, M., Griffiths-Jones, C. M., Hearn, K., Heightman, T. D., Iqbal, A., et al. (2017) · Journal of Medicinal Chemistry
Cell death mechanisms and regulationChemical Synthesis and Analysis
Cited by 72
- Verified
A protein tertiary structure mimetic modulator of the Hippo signalling pathway
Adihou, H., Gopalakrishnan, R., Förster, T., Guéret, S. M., Gasper, R., Geschwindner, S., Carrillo García, C., Karatas, H., Pobbati, A. V., Vazquez‐Chantada, M., et al. (2020) · Nature Communications
Hippo pathway signaling and YAP/TAZChemical Synthesis and Analysis
Cited by 58
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free